AMINOTETRAHYDROPYRANS AS DIPEPTIDYL PEPTIDASE-Ⅳ INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

摘要

The present invention is a novel substituted aminotetrahydro, which is an inhibitor of dipeptidyl peptidase-IV enzyme and useful in the treatment or prevention of diseases involving dipeptidyl peptidase-IV enzyme, such as diabetes, and especially type 2 diabetes. It's about piran. The invention also relates to pharmaceutical compositions comprising said compounds, and to the use of said compounds and compositions in the prevention or treatment of said diseases involving dipeptidyl peptidase-IV enzymes.